This review presents a pathology‐driven framework unifying nanomedicine across TBI, SCI, and PNI. Epidemiological evidence and comparative single‐cell transcriptomic reanalysis define shared pathological modules, injury‐specific effectors, and therapeutic bottlenecks. Six functional paradigms connect nanomaterial structure and biological fate to injury‐
Mouyuan Sun +12 more
wiley +1 more source
Comparative Immunohistochemical Analysis of FAP and c-MET Expression Across Renal Cell Carcinoma Subtypes: Preliminary Results and Potential Theranostic Implications. [PDF]
Unterrainer LM +8 more
europepmc +1 more source
Oxaliplatin‐resistant colorectal cancer cells utilize a previously unappreciated PLK1‐CEP55‐ESCRT‐driven vesicular extrusion mechanism to clear L‐OHP‐induced cellular damage. The natural withanolide Tubocapsenolide A directly targets and inhibits PLK1 to disrupt this specific damage‐clearance machinery. This blockade induces severe nucleolar stress and
Yueying Yang +15 more
wiley +1 more source
Adult Recurrent Wilms' Tumor Presenting as a Large Mass: A Case Report and Current Literature Review. [PDF]
Sevik C +5 more
europepmc +1 more source
Initial Clinical Experience With Gemcitabine, Cisplatin, and Nivolumab for Advanced Urothelial Carcinoma: A Four-case Series. [PDF]
Tsubota S +5 more
europepmc +1 more source
Fumarate Hydratase-Deficient Renal Cell Carcinoma in a Solitary Kidney: Diagnostic Pitfalls and Onco-Nephrology Constraints in an Older Adult With Chronic Kidney Disease. [PDF]
Sanka S +4 more
europepmc +1 more source
Durable Complete Response to Pembrolizumab for Postoperative Nodal Recurrence of Lynch Syndrome-Associated Upper Tract Urothelial Carcinoma: A Case Report. [PDF]
Atagi K +9 more
europepmc +1 more source

